P-78 USE OF ARTERIAL CONDUITS IN LIVER TRANSPLANTATION: OUTCOMES IN A SINGLE CENTRE IN PERU

• Published in: Annals of hepatology 2021-09, Vol.24, p.100441, Article 100441
• Main Authors: Solar Peche, Alfonso, Bacilio Calderon, Wilmer, Rondon Leyva, Carlos, Mantilla Cruzatti, Omar, Rivera Romani, José, Cardenas Ramirez, Bertha, Cerron Cabezas, Carmen, Montufar Valer, Augudberto, Espinoza Rivera, Saúl, Padilla Machaca, P. Martin
• Format: Article
• Language: English
• ISSN: 1665-2681; 2659-5982
• DOI: 10.1016/j.aohep.2021.100441

Being one of the South American countries with the cadaveric donor lowest rate, doesn't except us from having complex vascular inflow situation; Is in this context, the alternative of using arterial conduit to solve a poor arterial stream in recipients is always present. (ReTransplant, or risk factors of the Hepatic artery Thrombosis) Describe the outcome and the following of adult patient with arterial conduit in liver transplant at the Guillermo Almenara Irigoyen National Hospital 2000-2020. We Retrospectively reviewed, From March 2000 to February 2020, 274 Adult cadaveric liver Transplants have been performed, from this cohort we show use of 33 aortohepatic arterial ducts (12%) and the primary etiology was: NASH 11 cases (33,3%), follow by AIH 06 cases(18,2%) and VHC, Cryptogenic, CBP each with 04 cases meaning 12.1% respectively. It had been used in primary transplants in 25 cases (75,8%) and in 7 retransplant (25,2%); In 01 case (3%) we used as an alternative for a second retransplant. The global survival for the first years was 75% and 3 years survival was 71%. We identify 03 cases of complication (9%), having 01 hepatic arterial thrombosis, 01 partial arterial conduit thrombosis and 01 psedoaneurism arterial conduit. Performing an arterial conduit must be one of the feasible alternatives in complex situation in any liver transplant group. It is a save technique with no negative impact on survival and it seems to be associate with other vascular complications.